Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

I don’t think MNTA is looking to be acquired, but the BoD would, of course, have to consider any bona fide offer.

The most likely suitors, IMO, are the Japanese Big Pharma. The buyout premiums paid for small-cap biotechs vary widely, as you can see from the table in #msg-112225824.